As a member of the ADAM family of metalloproteases, ADAM‐17 involves in cell adhesion, migration, cellular signalling and proteolysis,13 recently emerging as a potential therapeutic target in several tumour types.14, 15. The gene discussed is ADAM17; the disease is neoplasm.